Invenomic Capital Management LP Takes $2.18 Million Position in Acadia Healthcare Company, Inc. $ACHC

Key Points

• Invenomic Capital Management LP purchased a new stake of approximately $2.18 million in Acadia Healthcare Company, acquiring 71,779 shares in the first quarter.
• Several institutional investors increased their positions in Acadia Healthcare, with GAMMA Investing LLC growing its holdings by 143.8%.
• Acadia Healthcare reported earnings of $0.83 per share, exceeding analysts’ expectations, with a revenue of $869.23 million for the quarter.

Invenomic Capital Management LP acquired a new stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) in the 1st quarter, according to the company in its most recent filing with the SEC. The fund acquired 71,779 shares of the company's stock, valued at approximately $2,176,000. Invenomic Capital Management LP owned approximately 0.08% of Acadia Healthcare as of its most recent SEC filing.

Several other hedge funds also recently modified their holdings of ACHC. UMB Bank n.a. increased its stake in shares of Acadia Healthcare by 149.5% in the 1st quarter. UMB Bank n.a. now owns 1,260 shares of the company's stock valued at $38,000 after acquiring an additional 755 shares in the last quarter. Caitong International Asset Management Co. Ltd grew its position in Acadia Healthcare by 11,218.2% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 1,245 shares of the company's stock valued at $38,000 after purchasing an additional 1,234 shares during the period. State of Wyoming acquired a new stake in Acadia Healthcare in the 4th quarter valued at $56,000. Covestor Ltd grew its position in Acadia Healthcare by 56.0% in the 1st quarter. Covestor Ltd now owns 2,262 shares of the company's stock valued at $69,000 after purchasing an additional 812 shares during the period. Finally, Twin Tree Management LP grew its position in Acadia Healthcare by 185.8% in the 1st quarter. Twin Tree Management LP now owns 5,691 shares of the company's stock valued at $173,000 after purchasing an additional 3,700 shares during the period.

Wall Street Analyst Weigh In

Several analysts recently issued reports on ACHC shares. Barclays reduced their price target on shares of Acadia Healthcare from $28.00 to $20.00 and set an "equal weight" rating for the company in a research report on Thursday, August 7th. Wall Street Zen raised shares of Acadia Healthcare from a "sell" rating to a "hold" rating in a research report on Sunday, August 3rd. Guggenheim reduced their price target on shares of Acadia Healthcare from $36.00 to $29.00 and set a "buy" rating for the company in a research report on Thursday, August 7th. Cowen reissued a "buy" rating on shares of Acadia Healthcare in a research report on Thursday, August 7th. Finally, Stephens raised shares of Acadia Healthcare to a "hold" rating in a research report on Monday, June 2nd. Nine equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $40.77.

Acadia Healthcare Price Performance

Shares of ACHC traded down $1.18 during midday trading on Monday, hitting $22.54. 2,885,977 shares of the company traded hands, compared to its average volume of 2,291,039. The stock has a 50-day moving average of $22.21 and a 200-day moving average of $24.59. Acadia Healthcare Company, Inc. has a one year low of $17.13 and a one year high of $79.82. The firm has a market cap of $2.08 billion, a P/E ratio of 14.93, a PEG ratio of 4.67 and a beta of 0.89. The company has a debt-to-equity ratio of 0.73, a current ratio of 1.32 and a quick ratio of 1.32.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last announced its quarterly earnings results on Tuesday, August 5th. The company reported $0.83 earnings per share for the quarter, beating the consensus estimate of $0.71 by $0.12. Acadia Healthcare had a return on equity of 8.34% and a net margin of 4.31%.The firm had revenue of $869.23 million for the quarter, compared to analysts' expectations of $839.59 million. During the same period in the prior year, the business posted $0.91 earnings per share. The company's revenue was up 9.2% on a year-over-year basis. Acadia Healthcare has set its FY 2025 guidance at 2.450-2.65 EPS. As a group, sell-side analysts predict that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current fiscal year.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.